SCHEMBL873312

SCHEMBL873312

CCCCCC[C@@H](O)C/C=C\CCCCCCC(C(C)=O)C(=O)OC(=O)C(O)CO

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.54
FFAR4 Q5NUL3 1/20 0.54
FAAH O00519 5/20 0.48
DGKA P23743 1/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
TRPV1 Q8NER1 1/20 0.39
PRKCA P17252 2/20 0.39
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCD Q05655 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
DEGS1 O15121 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5706336 0.86 FFAR1 (0.56) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL2122310 0.85 DGKA (0.57) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL5956405 0.84 FFAR1 (0.60) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL168985 0.84 FFAR1 (0.60) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL27505075 0.84 FFAR1 (0.60) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL2120986 0.84 FFAR1 (0.63) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL15686 0.84 FFAR1 (0.63) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL25237735 0.83 FFAR1 (0.59) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL29003110 0.83 FFAR1 (0.59) FFAR1FFAR4FAAHDGKANFKB1
SCHEMBL538471 0.83 FFAR1 (0.59) FFAR1FFAR4FAAHDGKANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11426338-B2 Nail compositions containing diisononyl 1,2-cyclohexanedicarboxylate L'ORÉAL (FR) 2022-08-30 US claimed
US-20090263338-A1 NAIL VARNISH L'OREAL (FR) 2009-10-22 US claimed
EP-1526829-A1 NAIL COSMETIC COMPOSITIONS Formule Diamancel Inc. (CA) 2005-05-04 EP claimed
WO-2003094870-A1 NAIL COSMETIC COMPOSITIONS FORMULE DIAMANCEL INC. (CA) 2003-11-20 WO claimed
US-20030064086-A1 Cosmetic compositions comprising nanoparticles and processes for using the same L'OREAL S.A. (FR) 2003-04-03 US claimed
WO-2003020226-A2 COSMETIC COMPOSITIONS COMPRISING NANOPARTICLES AND PROCESSES FOR USING THE SAME L'OREAL S.A. (FR) 2003-03-13 WO claimed
US-6203806-B1 PLASTICIZER, RESIN, AMINE AND/OR AMIDE; N-CHLOROSUCCINIMIDE AND/OR BORIC ACID L'OREAL S,A. (FR) 2001-03-20 US claimed
JP-55142037-A None JP disclosed
EP-3021830-B2 COMPOSITIONS AND METHODS FOR TREATING HAIR OREAL (FR) 2025-09-03 EP disclosed
US-12303582-B2 Composition for the treatment of nail fungus OYSTERSHELL NV (BE) 2025-05-20 US disclosed
EP-3519058-B1 COMPOSITIONS AND METHODS FOR TREATING HAIR OREAL (FR) 2023-06-07 EP disclosed
US-20210299022-A1 COMPOSITION FOR THE TREATMENT OF NAIL FUNGUS OYSTERSHELL NV (BE) 2021-09-30 US disclosed
EP-3884933-A1 COMPOSITION FOR THE TREATMENT OF NAIL FUNGUS Oystershell NV (BE) 2021-09-29 EP disclosed
EP-0605831-A1 Filler-containing resin composition and stretched films using same MITSUBISHI CHEMICAL CORPORATION (JP) 1994-07-13 EP disclosed
US-5326796-A Use of an arylsulphonylurethane as film forming resin in nitrocellulose nail varnishes, new arylsulphonylurethanes and new nitrocellulose nail varnishes SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1994-07-05 US disclosed
US-5057312-A Alkyl acrylate or methacrylate and hydroxyalkyl acrylate or methacrylate copolymer L'OREAL (FR) 1991-10-15 US disclosed
EP-0199325-B1 SILYL-CONTAINING NAIL ENAMEL Revlon, Inc. (US) 1989-11-15 EP disclosed
EP-0199325-A2 Silyl-containing nail enamel Revlon, Inc. (US) 1986-10-29 EP disclosed
US-4425326-A ADDITION COPOLYMERS, ACRYLIC ESTERS SOCIETE ANONYME DITE : L'OREAL (FR) 1984-01-10 US disclosed
JP-S55142037-A PACKAGING FILM MITSUBISHI PETROCHEM CO LTD 1980-11-06 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12303582-B2 Composition for the treatment of nail fungus DPM1, PIK3C3, ETF1 FFAR1 1629/4885FFAR4 1861/4885FAAH 2150/4885
US-20210299022-A1 COMPOSITION FOR THE TREATMENT OF NAIL FUNGUS DPM1, PIK3C3, ETF1 FFAR1 1629/4885FFAR4 1861/4885FAAH 2150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.